: Telangana aims to make life sciences a 0 billion industry #IndiaNEWS #Business Hyderabad, Feb 22 | Buoyed by the tremendous growth in the life sciences industry in Telangana amidst the pandemic

Telangana aims to make life sciences a 0 billion industry #IndiaNEWS #Business
Hyderabad, Feb 22 | Buoyed by the tremendous growth in the life sciences industry in Telangana amidst the pandemic over the last one year, the state government has set the vision to growing the sector to 0 billon dollars by 2030.
Our dream and vision of growing the life sciences industry to over USD 100 billion looks plausible and we remain committed to it, states industry minister K. T. Rama Rao told Bio Asia 2021, the annual flagship event which began here on Monday.
The life sciences sector in Telangana in terms of value is billion while in terms of cluster revenues it is billion. The potential for next 10 years is to move up to 0 billion of ecosystem valuation, said Dr Satish Reddy, Chairman, Reddys Laboratories, who heads the advisory committee constituted by the state government to prepare vision 2030 for the sector.
Referring to manufacturing of vaccines for Covid-19 in Hyderabad, Rama Rao said Hyderabads position as the vaccine capital of the world was further bolstered. I take pride in saying that Hyderabad rose to the occasion and made an impact for the world to witness. Our position as the vaccine capital of the world was further bolstered and it is a matter of pride that the world is looking to India and Hyderabad, he said.
KTR, as the minister is popularly known, claimed that Hyderabads life sciences ecosystem came forward and showed its fortitude in the last one year. He pointed out that when then US President Donald Trump requested Prime Minister Narendra Modi for supply of Remdesivir, they had to look towards Hyderabad.
He said the visit of foreign envoys from over 60 countries and that of the Prime Minister to Hyderabads Genome Valley is a testimony to the clusters significance in the global context.
KTR said Bharat Biotechs remarkable contribution and commitment to develop Indias first indigenous vaccine for Covid-19 is laudable. He also termed the efforts of Biological E, Indian Immunologicals and others as very significant and laudable. In addition, Hetero pharma and Dr. Reddys are augmenting the global supply by manufacturing and distributing Russian vaccine Sputnik. Further, Aurobindo Pharma is building world-class vaccine manufacturing facility with a capacity of about 450 million doses.
He exuded confidence that significant global population will be immunised with vaccines produced in Hyderabad saying this is no small feat to accomplish.
He pointed out that the life sciences sector in the state has attracted investments to the tune of about Rs. 3,700 crores in last one year with an employment potential for around 14,000 people.
A feather in our cap has been the approval of Umbralisib for cancer treatment.

Stock Market NEWS Best intraday tips Intraday Stocks below 100